According to IQVIA MAT July 2021, ibuprofen and famotidine tablets had estimated annual sales of $765 million in the U.S markets.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APis in over 100 markets. On a consolidated basis, the drug majors net profit soared 404.30% to Rs 548.16 crore on 22.2% jump in net sales to Rs 4,237.39 crore in Q1 FY22 over Q1 FY21.
Shares of Lupin were trading 0.79% higher at Rs 989.65 on BSE.
Powered by Capital Market - Live News